Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTSC sold 4% stake in Talis?
1
Aug 06, 2008 06:12AM

I have the same questions as you do...Did Talis issue more shares to the other partners to reduce our stake, or was it simply a sale of the shares we owned directly to them....those are the only two ways I can see our percentage go down 4%.

As far as you other points I agree with them also, did we sell them, at what price, profit??? maybe...and why wasn't it included in the original PR. As in most cases, each good PR leaves us with some unanswered questions.

Just as others have raised the points aqbout the acqusition/merger scenario, and the percent of money as compared to shares used...and more importantly, is it now or when will this "purchase" be accretive to our EPS???

Don't get me wrong I applaud the move, just wish we got the rest of the facts involved. May the next Q will give usmore information, but that is 4 months away. JMO

Share
New Message
Please login to post a reply